USANA Health Sciences(USNA) - 2025 Q2 - Quarterly Results

Second Quarter 2025 vs. Second Quarter 2024 Q2 2025 Financial Performance | Consolidated Results | | | | | --- | --- | --- | --- | | | | Year-Over-Year | Sequentially | | Net Sales | $236 million | +11% (No meaningful FX impact) | -5% | | Net Earnings | $9.7 million | -7% | +3% | | Diluted EPS | $0.52 | -4% | +6% | | (1) Adjusted Diluted EPS | $0.74 | +36% | +1% | | (2) Adjusted EBITDA | $30.5 million | +13% | +2% | Net earnings, EPS and EBITDA figures represent amounts attributable to USANA and excludes th ...